Universe Pharmaceuticals (UPC) Raw Materials (2021 - 2025)

Universe Pharmaceuticals (UPC) has 5 years of Raw Materials data on file, last reported at $2.5 billion in Q3 2025.

• For the quarter ending Q3 2025, Raw Materials rose 245.78% year-over-year to $2.5 billion; the trailing twelve-month figure through Sep 2025 stood at $2.5 billion (up 245.78% YoY), and the FY2025 full-year result was $2.5 billion, up 245.78% from the prior year.
• Raw Materials rose to $2.5 billion in Q3 2025, from $720.0 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $2.5 billion in Q3 2025 to a low of $607661.0 in Q3 2021.
• A 5-year average of $642.4 million and a median of $989043.0 in 2022 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials sank 35.76% in 2023 and soared 113221.79% in 2024, its largest moves.
• Tracing UPC's Raw Materials over 5 years: stood at $607661.0 in 2021, then jumped by 62.76% to $989043.0 in 2022, then slumped by 35.76% to $635395.0 in 2023, then soared by 113221.79% to $720.0 million in 2024, then surged by 245.78% to $2.5 billion in 2025.
• Business Quant data shows UPC's Raw Materials at $2.5 billion in Q3 2025, $720.0 million in Q3 2024, and $635395.0 in Q3 2023.